Similar articles

• Pyoderma gangrenosum with secondary pyarthrosis following propylthiouracil.

  Darben T, Savige J, Prentice R, Paspaliaris B, Chick J. Darben T, et al. Australas J Dermatol. 1999 Aug;40(3):144-6. doi: 10.1046/j.1440-0960.1999.00346.x. Australas J Dermatol. 1999. PMID: 10439526
• A case of propylthiouracil-induced pyoderma gangrenosum associated with antineutrophil cytoplasmic antibody.

  Hong SB, Lee MH. Hong SB, et al. Dermatology. 2004;208(4):339-41. doi: 10.1159/000077844. Dermatology. 2004. PMID: 15178918
• [Neutrophilic dermatosis associated with propylthiouracil-induced p-ANCA (p-antineutrophil cytoplasmic antibodies)].

  Boulenger-Vazel A, Kupfer-Bessaguet I, Gouedard C, Leberre R, Leroy JP, Sonnet E, Desvignes O, Misery L, Sassolas B. Boulenger-Vazel A, et al. Ann Dermatol Venereol. 2005 Jan;132(1):27-31. doi: 10.1016/s0151-9638(05)79191-2. Ann Dermatol Venereol. 2005. PMID: 15746603 French.
• [A pediatric case of myeloperoxidase-antineutrophil cytoplasmic (ANCA)-related crescentic glomerulonephritis associated with propylthiouracil treatment for Graves' disease].

  Kawasaki Y, Suzuki J, Sike T, Isome M, Nozawa R, Suzuki S, Kume K, Suzuki H. Kawasaki Y, et al. Nihon Jinzo Gakkai Shi. 1998 Nov;40(8):612-7. Nihon Jinzo Gakkai Shi. 1998. PMID: 9893462 Review. Japanese.
• [MPO-ANCA related vasculitis with pulmonary hemorrhage during propylthiouracil (PTU) therapy].

  Fujii A, Arimura Y, Minoshima S, Kobayashi M, Yoshihara K, Tanaka U, Nakabayashi K, Kitamoto K, Nagasawa T, Takahashi H. Fujii A, et al. Ryumachi. 1997 Dec;37(6):788-93. Ryumachi. 1997. PMID: 9492566 Review. Japanese.